Semin Thromb Hemost 2016; 42(01): 069-074
DOI: 10.1055/s-0035-1564840
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diagnostic Performance of a New Rapid Lateral Flow Immunoassay in Patients Suspected of Heparin-Induced Thrombocytopenia and Its Clinical Consequences

Clarisse Berroëta
1   Département d'Anesthésie, Institut Mutualiste Montsouris, Paris Cedex, France
,
Malvina Crespin
2   Laboratoire de Biologie, Institut Mutualiste Montsouris, Paris Cedex, France
,
Kamel Bouabdallah
3   Réanimation de chirurgie cardiaque, Institut Mutualiste Montsouris, Paris Cedex, France
,
Sophie Pargade
4   Service de Pharmacie, Institut Mutualiste Montsouris, Paris Cedex, France
,
François-Xavier Huchet
2   Laboratoire de Biologie, Institut Mutualiste Montsouris, Paris Cedex, France
,
Patrick Bourel
1   Département d'Anesthésie, Institut Mutualiste Montsouris, Paris Cedex, France
,
Ivan Philip*
1   Département d'Anesthésie, Institut Mutualiste Montsouris, Paris Cedex, France
,
Agathe Lebuisson*
2   Laboratoire de Biologie, Institut Mutualiste Montsouris, Paris Cedex, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. November 2015 (online)

Abstract

We prospectively evaluated the diagnostic accuracy of a new rapid assay (STic Expert HIT) alone or in combination with a clinical score in 90 HIT-suspected patients. The 4Ts score was calculated, and ELISA and serotonin-release assay (SRA) were performed; the average time taken for test results were 2 and 5 days for ELISA and SRA, respectively. The STic test was performed in our laboratory as an evaluation exercise and the result was available in 1 hour, but results were not communicated to the clinicians so as to not influence management. Diagnostic performance of STic test was assessed, alone and in combination with 4Ts score. HIT was diagnosed in 19 patients. The sensitivity, specificity, and positive and negative predictive values for the STic test alone were 95%, 92%, 75%, and 98%, respectively, with an accuracy of 92%. The likelihood ratio for positive and negative results with the STic test was 11.2 and 0.06. The combination of the 4Ts score and the STic test results had a negative predictive value of 100% and a negative likelihood ratio of 0. The favorable performance of the STic test may allow for the rapid exclusion of HIT in combination with a low to intermediate pretest clinical probability. During the subsequent year, using the STic test in real time to rapidly exclude the diagnosis, we observed a 50% reduction in danaparoid administration in HIT-suspected patients.

* Agathe Lebuisson and Ivan Philip have equally contributed to this article.


 
  • References

  • 1 Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. Annu Rev Med 2010; 61: 77-90
  • 2 Tan CW, Ward CM, Morel-Kopp MC. Evaluating heparin-induced thrombocytopenia: the old and the new. Semin Thromb Hemost 2012; 38 (2) 135-143
  • 3 Cuker A. Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost 2014; 40 (1) 106-114
  • 4 Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4 (4) 759-765
  • 5 Cuker A. Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis. Thromb Haemost 2011; 106 (6) 993-994
  • 6 Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?. Am J Hematol 2007; 82 (12) 1037-1043
  • 7 Bakchoul T, Giptner A, Najaoui A, Bein G, Santoso S, Sachs UJ. Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2009; 7 (8) 1260-1265
  • 8 Warkentin TE, Sheppard JI, Raschke R, Greinacher A. Performance characteristics of a rapid assay for anti-PF4/heparin antibodies: the particle immunofiltration assay. J Thromb Haemost 2007; 5 (11) 2308-2310
  • 9 Selleng S, Selleng K, Wollert HG , et al. Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. J Thromb Haemost 2008; 6 (3) 428-435
  • 10 Galea V, Khaterchi A, Robert F, Gerotziafas G, Hatmi M, Elalamy I. Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study. Platelets 2013; 24 (6) 441-447
  • 11 Minet V, Bailly N, Douxfils J , et al. Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: a retrospective study. Thromb Res 2013; 132 (3) 352-359
  • 12 Tardy B, Presles E, Akrour M, de Maistre E, Lecompte T, Tardy-Poncet B. Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?. J Thromb Haemost 2011; 9 (8) 1667-1669
  • 13 Demma LJ, Winkler AM, Levy JH. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Anesth Analg 2011; 113 (4) 697-702
  • 14 Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 2012; 120 (20) 4160-4167
  • 15 Berry C, Tcherniantchouk O, Ley EJ , et al. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients. J Am Coll Surg 2011; 213 (1) 10-17 , discussion 17–18
  • 16 Piednoir P, Allou N, Provenchère S , et al. Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients. J Cardiothorac Vasc Anesth 2012; 26 (4) 585-590
  • 17 Leroux D, Hezard N, Lebreton A , et al. Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert(®) HIT) for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2014; 166 (5) 774-782
  • 18 Cuker A, Arepally G, Crowther MA , et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 2010; 8 (12) 2642-2650
  • 19 Warkentin TE, Sheppard JA, Moore JC, Cook RJ, Kelton JG. Studies of the immune response in heparin-induced thrombocytopenia. Blood 2009; 113 (20) 4963-4969
  • 20 Sachs UJ, von Hesberg J, Santoso S, Bein G, Bakchoul T. Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT). Thromb Haemost 2011; 106 (6) 1197-1202
  • 21 Althaus K, Hron G, Strobel U , et al. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia. Thromb Res 2013; 131 (3) e85-e90
  • 22 Andrews DM, Cubillos GF, Paulino SK, Seckinger DL, Kett DH. Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia. Crit Care 2013; 17 (4) R143
  • 23 Minet V, Baudar J, Bailly N , et al. Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry. Thromb Res 2014; 133 (6) 1074-1078
  • 24 Nellen V, Sulzer I, Barizzi G, Lämmle B, Alberio L. Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients. Haematologica 2012; 97 (1) 89-97